Selection and use of lactic acid bacteria for reducing inflammation in mammals

Abstract

Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains

1 . (canceled)  
     
     
         2 . (canceled)  
     
     
         3 . A method for selecting a bacterial strain effective for treating inflammation in inflammatory bowel disease, comprising: using THP-1 monocytic cell line from a human source, to identify a strain which is effective in decreasing TNFα.  
     
     
         4 . A method for treating inflammation in inflammatory bowel disease, comprising administering cells of a bacterial strain selected according to  claim 3 .  
     
     
         5 . (canceled)  
     
     
         6 . A product for administration to a patient with inflammatory bowel disease comprising conditioned medium from a culture of a bacterial strain selected according to  claim 3 .  
     
     
         7 . A product for administration to a patient with inflammatory bowel disease comprising a culture of a bacterial strain selected according to  claim 3.